簡介

本頁面提供了有關 Burt A Adelman 已知的內部交易歷史的全面分析。內部人士包括公司的高管、董事或重要投資者。一般而言,基於內幕、非公開信息進行交易是非法的。這並不意味著他們在自己的公司進行任何交易都是非法的。但是,他們必須透過Form 4向美國證券交易委員會(SEC)報告所有交易。盡管存在這些限制,學術研究表明,內部人士 - 整體而言 - 在自己公司中的投資表現往往優於市場。

平均交易盈利能力

「平均交易盈利能力」衡量了內部人士在過去三年中所有非計劃性的公開市場購買交易的平均回報率。計算過程包括檢查每筆交易,排除了作為10b5-1交易計劃的一部分的交易。然後,對每筆交易在3、6和12個月的表現進行平均,以生成該筆交易最終的表現指標。最終,將所有交易的表現指標進行平均,計算出內部人士的總體平均表現指標。列表僅包含在過去兩年中進行過至少三筆交易的內部人士。

如果內部人士的交易盈利能力顯示為"N/A",則可能是因為該內部人士在過去三年內沒有進行任何公開市場購買交易,或者他們進行的交易距離現在太近,無法計算出可靠的表現指標。

更新頻率:每日

查看收益最高的的內幕交易者列表。

報告內部持倉的公司

SEC文件顯示Burt A Adelman已報告在以下公司擁有持倉或進行了交易:

證券 職位 最新報告的持倉
US:VERV / Verve Therapeutics, Inc. Director 0
US:CATB / Astria Therapeutics Inc Director 7,500
US:DYAX / Dyax Corp. CMO & EVP, R&D 0
US:BIIB / Biogen Inc. EVP, Development 10,933
如何解讀這些圖表

以下圖表顯示了在Burt A Adelman進行的每筆公開市場非計劃交易後證券的股價表現。非計劃交易是指沒有作為10b5-1交易計劃的一部分而進行的交易。股價表現以累積百分比變化的方式繪製。例如,如果一筆內部人士交易是在2019年1月1日進行的,該圖表將顯示該證券的每日百分比變化直至當前日期。如果在此期間股價從10美元漲至15美元,則股價的累積百分比變化將為50%。從10美元漲至20美元的價格變化將為100%,而從10美元跌至5美元的價格變化將為-50%。

最終,我們將評估內部人士的交易與股價的超額回報(正向或負向)之間的相關性,以判斷內部人士是否在交易中利用內部信息獲利。如果內部人士有這樣的行為,我們預期看到(a)購買後的正回報,或者(b)賣出後的負回報。對於情況(a),購買圖表將顯示一系列向上傾斜的曲線,表示每次購買後都有正回報。對於情況(b),賣出圖表將顯示一系列向下傾斜的曲線,表示每次賣出後都有負回報。

然而,僅憑這一點還不足以得出結論。例如,如果公司的股價在多年內呈現非周期性上升,我們會預期所有購買後的圖表都呈現向上傾斜。同樣地,多年來呈現非周期性下降的股價會導致賣出後的圖表也呈現向下傾斜。這兩種情況的圖表都不能表示內部人士在進行內幕交易。

最有力的指標是在公司股價呈極度循環波動的情況下,「購買」圖表顯示正向信號,而「賣出」圖表顯示負向趨勢。這種情況強烈暗示內部人士可能根據內幕信息精確地計時進行交易,以獲得財務優勢。

歷史內部人交易

該表格顯示了由 Burt A Adelman 進行的所有內幕交易的完整列表,這些交易已向美國證券交易委員會(SEC)披露。

呈報日期 交易日期 表格 證券代碼 證券 代碼 10b5-1 股份 剩餘股份 %
變化
每股
股價
交易
金額
剩餘
金額
2025-07-28 2025-07-25 4 VERV Verve Therapeutics, Inc.
Common Stock
U - Other -428,326 0 -100.00
2024-02-09 2023-09-18 5 VERV Verve Therapeutics, Inc.
Common Stock
G - Gift 37,168 428,326 9.50
2024-02-09 2023-09-18 5 VERV Verve Therapeutics, Inc.
Common Stock
G - Gift -37,168 0 -100.00
2024-02-09 2023-08-11 5 VERV Verve Therapeutics, Inc.
Common Stock
G - Gift 266,258 391,158 213.18
2024-02-09 2023-08-11 5 VERV Verve Therapeutics, Inc.
Common Stock
G - Gift -266,258 37,168 -87.75
2024-02-09 2022-11-07 5 VERV Verve Therapeutics, Inc.
Common Stock
G - Gift 106,200 124,900 567.91
2024-02-09 2022-11-07 5 VERV Verve Therapeutics, Inc.
Common Stock
G - Gift -106,200 303,426 -25.93
2022-05-13 2022-05-12 4 VERV Verve Therapeutics, Inc.
Common Stock
P - Purchase 10,000 18,700 114.94 12.15 121,526 227,254
2022-03-17 2022-03-15 4 VERV Verve Therapeutics, Inc.
Common Stock
P - Purchase 4,000 8,700 85.11 21.38 85,535 186,039
2021-12-06 2021-12-02 4 VERV Verve Therapeutics, Inc.
Common Stock
P - Purchase 4,700 4,700 31.34 147,304 147,304
2021-06-16 3 VERV Verve Therapeutics, Inc.
Common Stock
409,626
2020-06-12 2020-06-11 4 CATB CATABASIS PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 7,500 7,500
2019-06-05 2019-06-04 4 CATB CATABASIS PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 7,500 7,500
2018-06-07 2018-06-07 4 CATB CATABASIS PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 14,000 14,000
2017-07-28 2017-07-27 4 CATB CATABASIS PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 6,500 6,500
2016-04-07 2016-04-05 4 CATB CATABASIS PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 13,000 13,000
2016-01-22 2016-01-22 4 DYAX DYAX CORP
Stock Option (right to buy)
D - Sale to Issuer -500,000 0 -100.00
2016-01-22 2016-01-22 4 DYAX DYAX CORP
Stock Option (right to buy)
D - Sale to Issuer -225,000 0 -100.00
2016-01-22 2016-01-22 4 DYAX DYAX CORP
Stock Option (right to buy)
D - Sale to Issuer -235,000 0 -100.00
2016-01-22 2016-01-22 4 DYAX DYAX CORP
Stock Option (right to buy)
D - Sale to Issuer -233,749 0 -100.00
2016-01-22 2016-01-22 4 DYAX DYAX CORP
Stock Option (right to buy)
D - Sale to Issuer -68,542 0 -100.00
2016-01-22 2016-01-22 4 DYAX DYAX CORP
Stock Option (right to buy)
D - Sale to Issuer -42,232 0 -100.00
2016-01-22 2016-01-22 4 DYAX DYAX CORP
Common Stock
D - Sale to Issuer -208,602 0 -100.00
2016-01-15 2016-01-13 4 DYAX DYAX CORP
Stock Option (right to buy)
M - Exercise -1,251 233,749 -0.53
2016-01-15 2016-01-13 4 DYAX DYAX CORP
Stock Option (right to buy)
M - Exercise -1,458 68,542 -2.08
2016-01-15 2016-01-13 4 DYAX DYAX CORP
Stock Option (right to buy)
M - Exercise -140,268 42,232 -76.86
2016-01-15 2016-01-13 4 DYAX DYAX CORP
Common Stock
M - Exercise 1,251 208,602 0.60 3.00 3,753 625,806
2016-01-15 2016-01-13 4 DYAX DYAX CORP
Common Stock
M - Exercise 1,458 207,351 0.71 2.29 3,339 474,834
2016-01-15 2016-01-13 4 DYAX DYAX CORP
Common Stock
M - Exercise 140,268 205,893 213.74 1.48 207,597 304,722
2015-12-22 2015-12-22 4 DYAX DYAX CORP
Stock Option (right to buy)
M - Exercise -10,000 182,500 -5.19
2015-12-22 2015-12-22 4 DYAX DYAX CORP
Common Stock
M - Exercise 10,000 65,625 17.98 1.48 14,800 97,125
2015-12-18 2015-12-17 4 DYAX DYAX CORP
Stock Option (right to buy)
M - Exercise -27,500 192,500 -12.50
2015-12-18 2015-12-17 4 DYAX DYAX CORP
Common Stock
M - Exercise 27,500 55,625 97.78 1.48 40,700 82,325
2015-03-06 2015-03-05 4 DYAX DYAX CORP
Common Stock
S - Sale X -9,375 28,125 -25.00 15.66 -146,843 440,530
2015-02-20 2015-02-18 4 DYAX DYAX CORP
Stock Option (right to buy)
A - Award 500,000 500,000
2015-01-05 2015-01-02 4 DYAX DYAX CORP
Stock Option (right to buy)
M - Exercise -75,000 220,000 -25.42
2015-01-05 2015-01-02 4 DYAX DYAX CORP
Common Stock
S - Sale X -75,000 37,500 -66.67 14.05 -1,053,862 526,931
2015-01-05 2015-01-02 4 DYAX DYAX CORP
Common Stock
M - Exercise 75,000 112,500 200.00 1.48 111,000 166,500
2014-03-03 2014-03-03 4 DYAX DYAX CORP
Stock Option (right to buy)
M - Exercise -55,000 295,000 -15.71
2014-03-03 2014-03-03 4 DYAX DYAX CORP
Common Stock
S - Sale -55,000 37,500 -59.46 9.68 -532,400 363,000
2014-03-03 2014-03-03 4 DYAX DYAX CORP
Common Stock
M - Exercise 55,000 92,500 146.67 1.48 81,400 136,900
2014-03-03 2014-02-27 4 DYAX DYAX CORP
Stock Option (right to buy)
A - Award 225,000 225,000
2014-03-03 2014-02-27 4 DYAX DYAX CORP
Common Stock
A - Award 37,500 37,500 10.20 382,500 382,500
2013-04-01 2013-04-01 4 DYAX DYAX CORP
Stock Option (right to buy)
A - Award 235,000 235,000
2013-02-11 2013-02-07 4 DYAX DYAX CORP
Stock Option (right to buy)
A - Award 235,000 235,000
2012-10-12 2012-10-10 4 DYAX DYAX CORP
Stock Option (right to buy)
A - Award 70,000 70,000
2007-02-08 2007-02-06 4 BIIB BIOGEN IDEC INC
Restricted Stock Units
D - Sale to Issuer -5,467 10,933 -33.34
2007-02-08 2007-02-06 4 BIIB BIOGEN IDEC INC
Common Stock
F - Taxes -5,596 12,140 -31.55 48.94 -273,868 594,132
2007-02-08 2007-02-06 4 BIIB BIOGEN IDEC INC
Common Stock
M - Exercise 5,467 17,736 44.56
2006-02-08 2006-02-06 4 BIIB BIOGEN IDEC INC
Restricted Stock Units
A - Award 16,400 16,400
2006-02-08 2006-02-06 4 BIIB BIOGEN IDEC INC
Stock Option (right-to-buy)
A - Award 40,900 40,900
2005-02-22 2005-02-17 4 BIIB BIOGEN IDEC INC
Stock Option (right-to-buy)
A - Award 75,000 75,000
2004-05-06 2004-05-05 4 BIIB BIOGEN IDEC INC
Stock Option (right-to-buy)
M - Exercise -1,300 59,000 -2.16
2004-05-06 2004-05-05 4 BIIB BIOGEN IDEC INC
Stock Option (right-to-buy)
M - Exercise -1,100 60,300 -1.79
2004-05-06 2004-05-05 4 BIIB BIOGEN IDEC INC
Stock Option (right-to-buy)
M - Exercise -2,900 61,400 -4.51
2004-05-06 2004-05-05 4 BIIB BIOGEN IDEC INC
Stock Option (right-to-buy)
M - Exercise -500 64,300 -0.77
2004-05-06 2004-05-05 4 BIIB BIOGEN IDEC INC
Stock Option (right-to-buy)
M - Exercise -4,200 64,800 -6.09
2004-05-06 2004-05-05 4 BIIB BIOGEN IDEC INC
Common Stock
S - Sale -1,300 59,000 -2.16 58.30 -75,790 3,439,700
2004-05-06 2004-05-05 4 BIIB BIOGEN IDEC INC
Common Stock
M - Exercise 1,300 60,300 2.20 12.91 16,783 778,473
2004-05-06 2004-05-05 4 BIIB BIOGEN IDEC INC
Common Stock
S - Sale -1,100 60,300 -1.79 58.31 -64,141 3,516,093
2004-05-06 2004-05-05 4 BIIB BIOGEN IDEC INC
Common Stock
M - Exercise 1,100 61,400 1.82 12.91 14,201 792,674
2004-05-06 2004-05-05 4 BIIB BIOGEN IDEC INC
Common Stock
S - Sale -2,900 61,400 -4.51 58.29 -169,041 3,579,006
2004-05-06 2004-05-05 4 BIIB BIOGEN IDEC INC
Common Stock
M - Exercise 2,900 64,300 4.72 12.91 37,439 830,113
2004-05-06 2004-05-05 4 BIIB BIOGEN IDEC INC
Common Stock
S - Sale -500 64,300 -0.77 58.28 -29,140 3,747,404
2004-05-06 2004-05-05 4 BIIB BIOGEN IDEC INC
Common Stock
M - Exercise 500 64,800 0.78 12.91 6,455 836,568
2004-05-06 2004-05-05 4 BIIB BIOGEN IDEC INC
Common Stock
S - Sale -4,200 64,800 -6.09 58.26 -244,692 3,775,248
2004-05-06 2004-05-05 4 BIIB BIOGEN IDEC INC
Common Stock
M - Exercise 4,200 69,000 6.48 12.91 54,222 890,790
P
非衍生或衍生證券的公開市場或私下買入
S
非衍生或衍生證券的公開市場或私下賣出
A
公司向內部人員授予、獎勵或以其他方式獲取證券(例如股票期權)
C
衍生工具轉換
D
將證券賣出或轉讓回公司
F
使用從公司收到的證券的一部分來支付行使價或稅務負擔。
G
內部人士贈送或接收他人贈送公司股票
K
股權掉期和類似的避險交易
M
行使或轉換從公司獲得的衍生證券(例如期權)
V
內部人士透過Form 4自願報告的一筆交易
J
其他(附有交易描述的腳註)